Genentech, Inc. Tax Reduction Investment Plan is a defined contribution plan with a profit-sharing component and 401k feature. This plan has a BrightScope Rating of 87, placing it in the top 15% of all plans in its peer group. This plan is also in the top 15% of plans for Account Balances, Company Generosity, Salary Deferral, and Total Plan Cost. Genentech, Inc. Tax Reduction Investment Plan currently has over 14,600 active participants and over $1.8B in plan assets.
|1.||Fidelity Managed Income Portfolio||16%|
|2.||Vanguard Institutional Index||12%|
|3.||Fidelity Growth Company||12%|
1 Dna Way
South San Francisco, CA 94080
|Net Plan Assets||$1,780,000,000|
|Avg Account Balance||$120,000|
|sanofi-aventis US LLC||87.7|
|Hoffmann - La Roche||86.6|
|AstraZeneca Pharmaceuticals LP||83.6|
|Boehringer Ingelheim USA||80.2|
|Unilever United States||76.5|
Please visit the vault to keep your 401k plan information accurate and up-to-date.